1832 Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $355M | Buy |
918,237
+144,148
| +19% | +$53.5M | 0.18% | 64 |
|
|
2026
Q1 | $227M | Buy |
774,089
+11,893
| +2% | +$3.91M | 0.21% | 93 |
|
|
2025
Q4 | $267M | Buy |
762,196
+11,460
| +2% | +$3.87M | 0.2% | 75 |
|
|
2025
Q3 | $243M | Sell |
750,736
-34,100
| -4% | -$10.6M | 0.19% | 61 |
|
|
2025
Q2 | $305M | Sell |
784,836
-30,669
| -4% | -$12.3M | 0.24% | 51 |
|
|
2025
Q1 | $355M | Sell |
815,505
-6,070
| -0.7% | -$2.44M | 0.32% | 43 |
|
|
2024
Q4 | $303M | Buy |
821,575
+133,786
| +19% | +$56M | 0.26% | 46 |
|
|
2024
Q3 | $358M | Buy |
687,789
+72,051
| +12% | +$38.5M | 0.27% | 40 |
|
|
2024
Q2 | $334M | Sell |
615,738
-5,622
| -0.9% | -$2.97M | 0.27% | 42 |
|
|
2024
Q1 | $322M | Buy |
621,360
+41,605
| +7% | +$20.7M | 0.19% | 44 |
|
|
2023
Q4 | $273M | Buy |
579,755
+117,620
| +25% | +$54.4M | 0.39% | 49 |
|
|
2023
Q3 | $201M | Buy |
462,135
+33,836
| +8% | +$15.3M | 0.29% | 64 |
|
|
2023
Q2 | $190M | Buy |
428,299
+238,989
| +126% | +$110M | 0.23% | 70 |
|
|
2023
Q1 | $87M | Sell |
189,310
-137,684
| -42% | -$65.5M | 0.13% | 118 |
|
|
2022
Q4 | $168M | Buy |
326,994
+140,256
| +75% | +$71.2M | 0.28% | 77 |
|
|
2022
Q3 | $84.8M | Sell |
186,738
-386,088
| -67% | -$185M | 0.16% | 126 |
|
|
2022
Q2 | $276M | Sell |
572,826
-91,039
| -14% | -$45M | 0.48% | 51 |
|
|
2022
Q1 | $322M | Buy |
663,865
+395,356
| +147% | +$181M | 0.46% | 58 |
|
|
2021
Q4 | $127M | Sell |
268,509
-6,418
| -2% | -$2.7M | 0.22% | 109 |
|
|
2021
Q3 | $107M | Buy |
274,927
+24,404
| +10% | +$9.27M | 0.2% | 111 |
|
|
2021
Q2 | $95.3M | Buy |
250,523
+25,200
| +11% | +$9.63M | 0.18% | 127 |
|
|
2021
Q1 | $82.3M | Buy |
225,323
+44,287
| +24% | +$14.2M | 0.18% | 134 |
|
|
2020
Q4 | $57M | Sell |
181,036
-4,933
| -3% | -$1.51M | 0.13% | 145 |
|
|
2020
Q3 | $48.6M | Buy |
185,969
+50,996
| +38% | +$13.7M | 0.13% | 143 |
|
|
2020
Q2 | $35.2M | Sell |
134,973
-39,700
| -23% | -$10.6M | 0.11% | 151 |
|
|
2020
Q1 | $40.5M | Buy |
174,673
+87,307
| +100% | +$23.8M | 0.15% | 127 |
|
|
2019
Q4 | $26.7M | Sell |
87,366
-19,559
| -18% | -$5.38M | 0.08% | 168 |
|
|
2019
Q3 | $25.3M | Sell |
106,925
-21,331
| -17% | -$5.84M | 0.08% | 168 |
|
|
2019
Q2 | $36.2M | Sell |
128,256
-125,089
| -49% | -$34.2M | 0.12% | 147 |
|
|
2019
Q1 | $71.7M | Sell |
253,345
-129,496
| -34% | -$37.5M | 0.24% | 94 |
|
|
2018
Q4 | $100M | Buy |
382,841
+35,982
| +10% | +$9.89M | 0.4% | 68 |
|
|
2018
Q3 | $95M | Sell |
346,859
-22,933
| -6% | -$5.95M | 0.31% | 80 |
|
|
2018
Q2 | $87.7M | Buy |
369,792
+306,588
| +485% | +$71M | 0.3% | 80 |
|
|
2018
Q1 | $13.9M | Buy |
63,204
+6,900
| +12% | +$1.62M | 0.05% | 203 |
|
|
2017
Q4 | $12.6M | Sell |
56,304
-69,769
| -55% | -$14.9M | 0.04% | 214 |
|
|
2017
Q3 | $22.9M | Buy |
126,073
+121,278
| +2,529% | +$23.1M | 0.08% | 177 |
|
|
2017
Q2 | $903K | Buy |
4,795
+2,290
| +91% | +$411K | ﹤0.01% | 450 |
|
|
2017
Q1 | $414K | Sell |
2,505
-233,745
| -99% | -$37.2M | ﹤0.01% | 502 |
|
|
2016
Q4 | $33.7M | Sell |
236,250
-160,272
| -40% | -$21.5M | 0.1% | 184 |
|
|
2016
Q3 | $49.5M | Buy |
396,522
+30,222
| +8% | +$3.9M | 0.19% | 126 |
|
|
2016
Q2 | $48.2M | Sell |
366,300
-271,229
| -43% | -$37.1M | 0.19% | 119 |
|
|
2016
Q1 | $149M | Buy |
637,529
+33,903
| +6% | +$4.53M | 0.36% | 69 |
|
|
2015
Q4 | $84.7M | Sell |
603,626
-426
| -0.1% | -$58.7K | 0.37% | 74 |
|
|
2015
Q3 | $84.3M | Buy |
604,052
+296,889
| +97% | +$44.6M | 0.35% | 74 |
|
|
2015
Q2 | $49.9M | Sell |
307,163
-35,540
| -10% | -$5.68M | 0.17% | 128 |
|
|
2015
Q1 | $52.7M | Buy |
+342,703
| New | +$48.8M | 0.2% | 117 |
|
Other funds holding ELV
1832 Asset Management's ELV Position: Q2 2026 in Review
1832 Asset Management increased its Elevance Health (ELV) stake by 19% in Q2 2026, buying an estimated $53.5M and bringing the position to 918,237 shares worth $355M. The position accounts for 0.18% of the portfolio, ranked #64.
1832 Asset Management first reported a position in ELV in Q1 2015 and has held it in 46 quarters since. The position peaked at $358M in Q3 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- 1832 Asset Management held 918,237 shares of Elevance Health worth $355M as of Q2 2026.
- 1832 Asset Management bought 144,148 Elevance Health shares in Q2 2026, an estimated $53.5M.
- Elevance Health made up 0.18% of 1832 Asset Management's portfolio in Q2 2026, its #64 holding.
- 1832 Asset Management first reported a position in Elevance Health in Q1 2015 and has held it in 46 quarters since.
- 1832 Asset Management's Elevance Health position peaked at $358M in Q3 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.